Literature DB >> 6940184

Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus.

D L Mager, T W Mak, A Bernstein.   

Abstract

An in vitro colony method capable of detecting spleen cells malignantly transformed by Friend leukemia virus is described. These colony-forming cells, which form large erythroid colonies (10(4)-10(5) cells) in methylcellulose, can be detected late after infection with either the anemia-inducing (FV-A) or polycythemia-inducing (FV-P) isolates of Friend virus. Colony formation by these cells is dependent only on fetal calf serum as an exogeneous growth factor. The presence of these colony-forming cells in FV-P-infected spleens could not be detected until at least 3 weeks after virus infection, even though the most rapid increase in spleen weight occurred earlier, between 1 and 2 weeks after infection. Thereafter, the numbers of colony-forming cells increased sharply up to 5 weeks after infection with FV-P, beyond which time the mice generally did not survive. After infection with FV-A, colony-forming cells were detected only at 8-12 weeks and their numbers generally increased thereafter. Permanent cell lines were established from a significant fraction of FV-P and FV-A-induced colonies, and these cell lines could be chemically induced to synthesize hemoglobin. All individual colonies produced complete Friend virus complex. However, virus production appeared to decline in at least some cell lines. Both FV-P- and FV-A-induced colonies contained cells capable of forming spleen colonies in irradiated recipients and subcutaneous tumors in unirradiated mice. Thus, the assay method described here appears to detect a unique class of malignant Friend virus-transformed cells that can be detected only in the advanced stages of Friend virus-induced erythroleukemia.

Entities:  

Mesh:

Year:  1981        PMID: 6940184      PMCID: PMC319201          DOI: 10.1073/pnas.78.3.1703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

2.  A transplantable reticulum-cell sarcoma variant of Friend's viral leukemia.

Authors:  R F BUFFETT; J FURTH
Journal:  Cancer Res       Date:  1959-11       Impact factor: 12.701

3.  Erythropoietin-independent erythroid colony formation in vitro by hemopoietic cells of mice infected with friend virus.

Authors:  S K Liao; A A Axelrad
Journal:  Int J Cancer       Date:  1975-03-15       Impact factor: 7.396

4.  Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.

Authors:  C Friend; W Scher; J G Holland; T Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

5.  Erythrocytic maturation of (Friend) virus-induced leukemic cells in spleen clones.

Authors:  G B Rossi; C Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1967-10       Impact factor: 11.205

6.  Transformation of DBA/2 mouse fetal liver cells infected in vitro by the anemic strain of Friend leukemia virus.

Authors:  D W Golde; N Bersch; C Friend; D Tsuei; W Marovitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

7.  Pure and mixed erythroid colony formation in vitro stimulated by spleen conditioned medium with no detectable erythropoietin.

Authors:  G R Johnson; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

8.  Friend leukemia: rapid development of erythropoietin-independent hematopoietic precursors.

Authors:  J S Horoszewicz; S S Leong; W A Carter
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

9.  Anemia- and polycythemia-inducing isolates of Friend spleen focus-forming virus. Biological and molecular evidence for two distinct viral genomes.

Authors:  M E MacDonald; F H Reynolds; W J Van de Ven; J R Stephenson; T W Mak; A Bernstein
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

10.  Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice.

Authors:  H A Freedman; F Lilly
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  26 in total

1.  Clonal analysis of the late stages of erythroleukemia induced by two distinct strains of Friend leukemia virus.

Authors:  D Mager; M E MacDonald; I B Robson; T W Mak; A Bernstein
Journal:  Mol Cell Biol       Date:  1981-08       Impact factor: 4.272

2.  A deletion in the Friend spleen focus-forming virus env gene is necessary for its product (gp55) to be leukemogenic.

Authors:  N Watanabe; M Nishi; Y Ikawa; H Amanuma
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

3.  In vitro-derived leukemic erythroid cell lines induced by a raf- and myc-containing retrovirus differentiate in response to erythropoietin.

Authors:  S P Klinken; N A Nicola; G R Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Spi-1/PU.1 transgenic mice develop multistep erythroleukemias.

Authors:  F Moreau-Gachelin; F Wendling; T Molina; N Denis; M Titeux; G Grimber; P Briand; W Vainchenker; A Tavitian
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

5.  Role of N-terminal sequences of the tyrosine kinase sf-Stk in transformation of rodent fibroblasts by variants of Friend spleen focus-forming virus.

Authors:  Daigo Umehara; Maki Kawamura; Yuka Odahara; Shinya Watanabe; Charlotte Hanson; Sandra Ruscetti; Kazuo Nishigaki
Journal:  Int J Cancer       Date:  2011-12-05       Impact factor: 7.396

6.  Expression of a transformation-related protein (p53) in the malignant stage of Friend virus-induced diseases.

Authors:  S K Ruscetti; E M Scolnick
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

7.  Isolation and induction of erythroleukemic cell lines with properties of erythroid progenitor burst-forming cell (BFU-E) and erythroid precursor cell (CFU-E).

Authors:  T Shibuya; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia.

Authors:  F Mélet; B Motro; D J Rossi; L Zhang; A Bernstein
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

9.  Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin.

Authors:  P Johnson; S Chung; S Benchimol
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

10.  Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes.

Authors:  V Chow; Y Ben-David; A Bernstein; S Benchimol; M Mowat
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.